Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review. - Wikidata - awgldk - TriplyDB

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

http://www.wikidata.org/entity/Q34101953

about

Harms and benefits of adoptive immunotherapy for postoperative hepatocellular carcinoma: an updated review Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension.Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy.Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review.Conventional oral systemic chemotherapy for postoperative hepatocellular carcinoma: A systematic review Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects.Multiple courses of immunotherapy with different immune cell types for patients with hepatocellular carcinoma after microwave ablation.Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy.Thymosin α1 therapy subsequent to radical hepatectomy in patients with hepatitis B virus-associated hepatocellular carcinoma: A retrospective controlled study Systemic therapies in hepatocellular carcinoma: present and future.Postoperative therapy options for hepatocellular carcinoma.Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects.Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review.Specific immunotherapy in hepatocellular cancer: A systematic review.The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma.Adjuvant sorafenib in hepatocellular carcinoma: A cautionary comment of STORM trial.The 4th Asia-Pacific Primary Liver Cancer Expert Meeting Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review

P2860

Q33567018-79A240B7-5AD7-4FC8-B4B7-07A9E1DECCBD Q33895113-F0A30A4D-5479-4BD5-B888-B7D918925E7B Q34277957-BF21FFC5-8AF3-4D95-BEDE-5B9E5680402B Q34600849-B8F6E35E-558E-478B-82E0-8685DA5A1505 Q35209230-DDF5F3BC-7DAD-426B-810C-0E714BCBC38F Q35298023-BA405AA3-F3C6-4E27-A9CB-FC807B832643 Q35514419-83DBFF05-6867-4BF3-BB86-D55E40E7D439 Q36081479-6ED8D4D6-A081-4EBB-BFE8-9694204F47B6 Q36322143-5BAD9DF4-83E5-4C5D-8BA2-7F03B197ED48 Q37386235-603DCD91-746E-460E-8DFB-204DCB8D17C0 Q37407043-EBE710E2-0D72-4A00-B049-B1BBFA77E3DD Q38150875-6D684ABA-E968-4530-8CA1-2A1B48B8AC77 Q38203306-AC46E0B7-CFC1-40FF-9906-FA80EC2354C2 Q38231581-9C9E145C-0E02-4996-9F36-6336D41ABA1B Q38239587-EAA70999-3642-4F12-B669-B380526D4D33 Q38840178-8C05AC86-73CB-412B-B080-BD1F52D42D7A Q39535683-2654999F-AC60-4EDA-AE7A-78C431DF2F34 Q42286093-9AC40DCE-B9D0-4A01-8839-0F56CB3D709E Q42345959-295C32FF-129E-4E06-B4DA-193C39994BAC Q47121517-2DCE6255-FF72-4DFA-90BD-C74C7D913A27 Q58755253-6B56AFE1-69E0-45B5-BCE4-B94EFB559258

P2860

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

http://www.wikidata.org/entity/Q34101953

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

@ast

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

@en

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

@nl

type

label

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

@ast

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

@en

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

@nl

prefLabel

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

@ast

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

@en

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

@nl

P1433

Q34101953-8AC1CE03-270D-433A-897F-3A0C4717D271

P1476

Q34101953-94FAE337-D6CD-4894-BEB0-2866B9FDF4B1

P2093

Q34101953-01FC0209-14E2-4E72-A3E8-85E6A5F48B3E

Q34101953-0E48155D-44C0-4F24-9E05-F491568A57EE

Q34101953-24451CC9-5B67-4D8E-A174-EC71D6195E1A

Q34101953-4677D16A-CD98-4981-80A1-2AD68CF483B8

Q34101953-4B01A6CF-801B-474C-AE8B-92589F1D5979

Q34101953-650A1A2A-AEAE-4315-840C-A870E1F2EAFD

Q34101953-8D5C7C8D-72D3-4AF9-B216-373DDCD887F3

Q34101953-91ED7F4D-BE65-44D1-A2CC-1C0757D59063

Q34101953-CFE6B2B4-5A2A-4321-B6FF-DE6E5893BBAB

Q34101953-E4149798-AACB-4A1A-97E1-57AAD646C82C

P2860

Q34101953-0B31D265-79E2-418C-8886-B75905714D69

Q34101953-0DD00563-0E0D-4B86-A21B-A82EE004151D

Q34101953-0FCEE562-560B-4680-917D-3DB6F770875C

Q34101953-1959AE5E-0F6C-48B1-929C-F201AFC91A4E

Q34101953-1EF064FA-D2A4-4347-937B-476104B4BE5D

Q34101953-2DD00434-45DF-4DAF-B4CB-DB2258E924A4

Q34101953-3030EB07-7F3F-46EC-8991-22C93DE723BA

Q34101953-39348C77-E931-446D-98AF-794004F4213E

Q34101953-4CD264BC-A433-4442-92BE-300C61252D35

Q34101953-52AF6BAF-471D-4599-AAAC-55689CFB462A

P304

Q34101953-0C82DB09-1D89-41C7-933E-76E3051C9767

P31

Q34101953-551C2002-DC6B-483D-911D-89A27F684DB2

P356

Q34101953-04DB2746-6E29-4740-8F1B-40BEA38AEFB7

P433

Q34101953-41DEF3AC-C94A-4981-8031-713FDD4C2DA4

P478

Q34101953-5A23C60A-2B28-435E-96DD-1E00C9784B9E

P577

Q34101953-C7BF10F0-7489-4524-8E79-96966879C9CD

P5875

Q34101953-2BEDB927-C7C5-4A37-A54C-8E289080E8D1

P698

Q34101953-A178D91A-8D7E-41A9-B132-B64DE5BA7646

P921

Q34101953-7153EA01-4A60-43C5-9A22-6E5A809CEEED

P356

J.1742-1241.2011.02814.X

P1433

International Journal of Clinical Practice

P1476

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review.

@en

P2093

F-X Wu

http://www.w3.org/2001/XMLSchema#string

J-H Zhong

http://www.w3.org/2001/XMLSchema#string

L Ma

http://www.w3.org/2001/XMLSchema#string

L-C Wu

http://www.w3.org/2001/XMLSchema#string

L-Q Li

http://www.w3.org/2001/XMLSchema#string

S Huang

http://www.w3.org/2001/XMLSchema#string

W Zhao

http://www.w3.org/2001/XMLSchema#string

W-P Yuan

http://www.w3.org/2001/XMLSchema#string

X M You

http://www.w3.org/2001/XMLSchema#string

Z-M Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

Sorafenib in advanced hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Hepatocellular carcinoma

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.

Design and rationale for the non-interventional Global Investigation of Therapeutic DEcisions in Hepatocellular Carcinoma and Of its Treatment with Sorafenib (GIDEON) study.

Possibility of adoptive immunotherapy with peripheral blood-derived CD3⁻CD56+ and CD3+CD56+ cells for inducing antihepatocellular carcinoma and antihepatitis C virus activity.

Current status of adoptive immunotherapy of malignancies.

Medical treatments for hepatocellular carcinoma (HCC): what's next?

P304

21-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1742-1241.2011.02814.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51881933

http://www.w3.org/2001/XMLSchema#string

P698

22171902

http://www.w3.org/2001/XMLSchema#string

P921